GlassScriptPhysician profile
Daniel S Cosgrove
NPI 1235257429
$61,284.04
in general payments reported to CMS, 2019-2025
26 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Public Health & General Preventive Medicine providers received nationally (typical 2025 total: $95.27).
See the full distribution for Public Health & General Preventive Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $129 · 2021: $4,866 · 2022: $6,254 · 2023: $11K · 2024: $25K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48K · Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,234.35 |
| Food and Beverage | $1,397.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $47,028.93 | 2023-2025 | |
| Allergan, INC. | $11,040.25 | 2019-2023 | |
| Amgen INC. | $960.24 | 2019-2025 | Repatha, Otezla, Evenity |
| Illumina, INC. | $804.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $175.87 | 2022-2025 | |
| Conformis, INC. | $157.90 | 2019 | |
| Novo Nordisk INC | $133.06 | 2022-2024 | Wegovy |
| Nevro Corp. | $124.78 | 2022 | |
| Heartflow, INC. | $120.57 | 2025 | |
| Biogen, INC. | $118.41 | 2021-2025 | Leqembi |
| Seqirus USA INC | $92.72 | 2019 | |
| Lilly USA, LLC | $69.85 | 2021-2025 | Amyvid, Kisunla |
| Eisai INC. | $66.46 | 2021-2025 | |
| Ge Healthcare | $62.56 | 2024 | |
| Esperion Therapeutics, INC. | $47.98 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $37.47 | 2023-2025 | Watchpatone |
| Radius Health, INC. | $33.21 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $32.21 | 2021 | |
| Acella Pharmaceuticals, LLC | $32.15 | 2023-2025 | NP Thyroid 60 |
| Pfizer INC. | $31.47 | 2023 | |
| Glaxosmithkline, LLC. | $22.82 | 2020 | |
| Exact Sciences Corporation | $21.44 | 2023 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $19.56 | 2023 | Inspire |
| Astellas Pharma US INC | $18.54 | 2024 | Xtandi |
| Myriad Genetic Laboratories, INC. | $17.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cosgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.